Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0QQ7D
|
||||
Former ID |
DAP000926
|
||||
Drug Name |
Tazobactam
|
||||
Synonyms |
TAZ; CL298741; YTR830H; CL-298741; Piprataz (TN); Tazocin (TN); YTR-830H; Zosyn (TN); Tazobactam (JAN/USAN/INN); (2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4; (2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99] | Approved | [536361] | ||
Therapeutic Class |
Antiinfective Agents
|
||||
Company |
Gepach International
|
||||
Structure |
Download2D MOL |
||||
Formula |
C10H12N4O5S
|
||||
Canonical SMILES |
CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3
|
||||
InChI |
1S/C10H12N4O5S/c1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19/h2-3,7-8H,4-5H2,1H3,(H,16,17)/t7-,8+,10+/m1/s1
|
||||
InChIKey |
LPQZKKCYTLCDGQ-WEDXCCLWSA-N
|
||||
CAS Number |
CAS 89786-04-9
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9973, 584542, 604755, 7847726, 7890688, 7980730, 10240806, 14751709, 16012340, 29303858, 46508088, 48416593, 50192512, 90444495, 92711477, 93166370, 103163870, 103949887, 104418948, 126630815, 126657306, 131329684, 134338202, 135693792, 135841765, 137248595, 137981849, 152100220, 160964843, 162009787, 164196449, 175267759, 175607558, 177749299, 179316265, 184544899, 184816524, 196106439, 198993457, 223438269, 223554784, 223684636, 223703155, 224294474, 226493626, 241152814, 249868384, 251912318, 251916632, 252074045
|
||||
SuperDrug ATC ID |
J01CG02
|
||||
SuperDrug CAS ID |
cas=089785842
|
||||
Target and Pathway | |||||
Target(s) | Beta-lactamase | Target Info | Inhibitor | [537578] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.